{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:52:25Z","timestamp":1780584745222,"version":"3.54.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cld.2021.01.006","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:43:29Z","timestamp":1615423409000},"page":"357-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation?"],"prefix":"10.1016","volume":"25","author":[{"given":"Salvatore","family":"Piano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2021.01.006_bib1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2021.01.006_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2021.01.006_bib4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib5","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib6","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/ajg.2017.19","article-title":"Bacterial infections change natural history of cirrhosis irrespective of liver disease severity","volume":"112","author":"Dionigi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2021.01.006_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/liv.13645","article-title":"Infections complicating cirrhosis","volume":"38","author":"Piano","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2021.01.006_bib9","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1378\/chest.124.3.1016","article-title":"Cirrhosis as a risk factor for sepsis and death: analysis of the national hospital discharge survey","volume":"124","author":"Foreman","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.cld.2021.01.006_bib10","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide","volume":"156","author":"Piano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"Fern\u00e1ndez","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1590-8658(01)80134-1","article-title":"Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study","volume":"33","author":"Borzio","year":"2001","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2021.01.006_bib13","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/hep.25947","article-title":"Second infections independently increase mortality in hospitalized patients with cirrhosis: the north American Consortium for the study of end-stage liver disease (NACSELD) experience","volume":"56","author":"Bajaj","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib14","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib15","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2021.01.006_bib17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cld.2021.01.006_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/hep.29791","article-title":"Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort","volume":"68","author":"Bajaj","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib21","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0168-8278(18)30240-X","article-title":"Gut microbiome is profoundly altered in acute-on-chronic liver failure as evaluated by quantitative metagenomics. Relationship with liver cirrhosis severity","volume":"68","author":"Sole","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.30349","article-title":"Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis","volume":"70","author":"Mu\u00f1oz","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jhep.2013.03.012","article-title":"Increased risk of cognitive impairment in cirrhotic patients with bacterial infections","volume":"59","author":"Merli","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/bjs.1800730916","article-title":"Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage","volume":"73","author":"Bleichner","year":"1986","journal-title":"Br J Surg"},{"key":"10.1016\/j.cld.2021.01.006_bib26","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0016-5085(92)91514-5","article-title":"Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage","volume":"103","author":"Soriano","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/gutjnl-2015-310275","article-title":"Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)","volume":"66","author":"Nahon","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cld.2021.01.006_bib28","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.cld.2021.01.006_bib29","first-page":"36","article-title":"Bacterial infections in patients with compensated cirrhosis and clinically significant portal hypertension: implications on the risk of developing decompensation and on survival","volume":"70","author":"Villanueva","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib30","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1136\/gutjnl-2017-314324","article-title":"Assessment of sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections","volume":"67","author":"Piano","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cld.2021.01.006_bib31","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute on chronic liver failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.cld.2021.01.006_bib34","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cld.2021.01.006_bib35","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/0016-5085(95)90146-9","article-title":"Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study","volume":"108","author":"Bernard","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12072-015-9641-1","article-title":"Sepsis-induced acute kidney injury in patients with cirrhosis","volume":"10","author":"Angeli","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cld.2021.01.006_bib38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/hep.28414","article-title":"The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis","volume":"64","author":"Bajaj","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib39","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/ajg.2017.253","article-title":"Predictors of early readmission in patients with cirrhosis after the resolution of bacterial infections","volume":"112","author":"Piano","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2021.01.006_bib40","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib41","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib42","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2017.12.027","article-title":"Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis","volume":"68","author":"Turco","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jhep.2014.09.005","article-title":"Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure","volume":"62","author":"Romero-G\u00f3mez","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib44","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Cl\u00e0ria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib45","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1053\/j.gastro.2018.07.022","article-title":"Simvastatin prevents progression of acute on chronic liver failure in rats with cirrhosis and portal hypertension","volume":"155","author":"Tripathi","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib46","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhep.2010.03.011","article-title":"Mechanisms of TNF\u03b1-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNF\u03b1 and endocannabinoids","volume":"53","author":"Yang","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2021.01.006_bib47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","article-title":"Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms","volume":"57","author":"Bortoluzzi","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1742-2094-7-66","article-title":"Marked potentiation of cell swelling by cytokines in ammonia-sensitized cultured astrocytes","volume":"7","author":"Rama Rao","year":"2010","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.cld.2021.01.006_bib49","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/hep.21599","article-title":"Endotoxemia produces coma and brain swelling in bile duct ligated rats","volume":"45","author":"Wright","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib50","doi-asserted-by":"crossref","first-page":"eaar3932","DOI":"10.1126\/science.aar3932","article-title":"An evolutionary perspective on immunometabolism","volume":"363","author":"Wang","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cld.2021.01.006_bib51","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","article-title":"Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF","volume":"72","author":"Moreau","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib53","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/hep.510270504","article-title":"Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage","volume":"27","author":"Goulis","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib54","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hep.1840160318","article-title":"Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration","volume":"16","author":"Llach","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib55","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0016-5085(93)90284-J","article-title":"Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites","volume":"104","author":"Andreu","year":"1993","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2021.01.006_bib56","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/hep.26535","article-title":"Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death","volume":"58","author":"Acevedo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib57","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cgh.2019.09.035","article-title":"Including relative adrenal insufficiency in definition and classification of acute-on-chronic liver failure","volume":"18","author":"Piano","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib58","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/hep.1840190313","article-title":"Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis","volume":"19","author":"Bolognesi","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib59","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/hep.1840050419","article-title":"Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis","volume":"5","author":"Runyon","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib60","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","article-title":"Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis","volume":"154","author":"Sim\u00f3n-Talero","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2021.01.006_bib61","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1053\/j.gastro.2014.11.045","article-title":"Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK","volume":"148","author":"Bernsmeier","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib62","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/gutjnl-2017-314184","article-title":"CD14(+) CD15(-) HLA-DR(-) myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure","volume":"67","author":"Bernsmeier","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cld.2021.01.006_bib63","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","article-title":"Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding \u2013 an updated Cochrane review","volume":"34","author":"Chavez-Tapia","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2021.01.006_bib64","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1053\/j.gastro.2006.07.010","article-title":"Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage","volume":"131","author":"Fern\u00e1ndez","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib65","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fern\u00e1ndez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib66","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1053\/j.gastro.2018.08.026","article-title":"Effects of long-term norfloxacin therapy in patients with advanced cirrhosis","volume":"155","author":"Moreau","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib67","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","article-title":"Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial","volume":"12","author":"Gin\u00e8s","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib68","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study","volume":"55","author":"Fern\u00e1ndez","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib69","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2021.01.006_bib70","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.28898","article-title":"Rifaximin has no effect on hemodynamics in decompensated cirrhosis: a randomized, double-blind, placebo-controlled trial","volume":"65","author":"Kimer","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12072-019-10010-3","article-title":"Adverse outcomes of proton pump inhibitors in chronic liver disease: a systematic review and meta-analysis","volume":"14","author":"Wang","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cld.2021.01.006_bib72","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1478-3231.2009.02038.x","article-title":"\u03b2-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis","volume":"29","author":"Senzolo","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2021.01.006_bib73","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2021.01.006_bib74","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/cells9030604","article-title":"Propranolol suppresses the T-Helper cell depletion-related immune dysfunction in cirrhotic mice","volume":"9","author":"Tsai","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cld.2021.01.006_bib75","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2021.01.006_bib76","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/liv.13968","article-title":"Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites","volume":"39","author":"Di Pascoli","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2021.01.006_bib77","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3516","article-title":"Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2","volume":"20","author":"O\u2019Brien","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.cld.2021.01.006_bib78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis","volume":"157","author":"Fern\u00e1ndez","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib79","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib80","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1053\/j.gastro.2016.01.004","article-title":"Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis","volume":"150","author":"Abraldes","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.006_bib81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2468-1253(19)30320-6","article-title":"Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"5","author":"Pose","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib82","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jhep.2019.06.017","article-title":"FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis","volume":"71","author":"Sorribas","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib83","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jhep.2020.01.017","article-title":"Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis","volume":"72","author":"Bajaj","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib84","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial","volume":"63","author":"Piano","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2021.01.006_bib85","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.28332","article-title":"An empirical broad spectrum antibiotic therapy in health-care\u2013associated infections improves survival in patients with cirrhosis: a randomized trial","volume":"63","author":"Merli","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.006_bib86","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2021.01.006_bib87","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","article-title":"Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study","volume":"57","author":"Guevara","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib88","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","article-title":"Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial","volume":"62","author":"Th\u00e9venot","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.006_bib89","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cgh.2019.07.055","article-title":"Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis","volume":"18","author":"Fern\u00e1ndez","year":"2020","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326121000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326121000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:58:06Z","timestamp":1761069486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326121000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1089326121000064"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2021.01.006","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation?","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2021.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}